Narayana HrudayaQ1 FY27
Narayana Hrudaya Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹1,881P/E: 43.0Market Cap: ₹37.1K CrSector: Healthcare Services
Management growth scorecard
Revenue
Category 3
Margin
Category 2
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- →India hospital business shows strong revenue growth driven by a combination of increased footfalls and ARPOB (Average Revenue Per Occupied Bed).
- →Clinics contribute significantly, with OP consults growing about 30% YoY and 66,000 consultations in Q1, supporting hospital footfalls and overall revenue.
- →Expansion plans include adding new beds, such as the Southwest Bangalore project expected to start by end of Q2 FY27.
- →Focused capital deployment in clusters where the company already has presence, with possible new geographic markets considered after Phase 1 progress.
- →Efforts to change payer mix in the UK from mainly NHS to a more balanced one with private and self-pay revenues, expected to increase private contribution over time.
- →Insurance business is growing despite current losses, with initiatives underway to improve underwriting, claims management, and profitability as the book scales.
- →Margin expansion expected through operational efficiencies, technology adoption, and standardized consumables and implants.
Margin guidance
Category 2- →Debt levels expected to rise for the next 2-3 years due to project construction but anticipated to reduce by FY30, improving financials.
- →India business EBITDA margins showed a strong 400 bps year-on-year expansion despite integration costs; overall margin trajectory expected to improve medium-term.
- →UK business earnings expected to improve with operational synergies and certifications completed; currently early to measure ROCE but upside exists.
- →Cayman Insurance losses have reduced sequentially; pricing adjustments and renewals signal improvements; breakeven expected over time.
- →India hospitals’ revenue growth driven by combination of increased footfalls and ARPOB, focusing on high-end procedures and technology use.
- →Margin expansion expected from cost efficiencies (standardizing implants/drugs, consolidating vendors) and engagement with consultants on productivity models.
- →Insurance business profitability will improve through premium increases, better risk selection, and reduction in operating expenses.
- →Overall, mid-to-long-term positive earnings growth forecast based on operational improvements and strategic capital deployment.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →The company is currently managing its debt prudently; the net debt-to-EBITDA ratio is less than 1 and debt-equity ratio is not very high.
- →Debt levels are expected to rise in the next 2-3 years as project construction gains pace.
- →By FY30, debt ratios are anticipated to decrease to levels lower than the current figures.
- →Cash reserves have increased from FY25 to FY26, primarily from operating business performance in India and Cayman.
- →These cash reserves, along with borrowing, will be deployed towards committed projects worth INR 3,000 crores over the next two years.
- →No specific mention of new equity fundraising was made in the provided excerpt.
- →The company balances operational cash flow retention with investments into growth verticals and expansion initiatives.
Order book
- →The transcript does not explicitly mention the current or expected order book or pending orders for Narayana Hrudayalaya Limited.
- →Capital deployment and expansion plans are outlined over the next 3 financial years focused on clusters with existing strong presence.
- →A few projects have been postponed from FY28 to FY29 and FY30 due to minor delays such as licensing issues, mostly within acceptable timelines.
- →The Southwest Bangalore 100-bed project is expected to be operational by end of Q2 FY27.
- →The company continues to monitor project timelines closely and expects that most will proceed as planned.
- →No specific quantitative data related to order book or pending orders is available in the provided pages.
Capex plans
Yes- →The company has an outlined capital deployment plan focused on expansion within clusters where they already have a strong presence, over the next 3 financial years.
- →Projects include hospital expansions such as the North Bangalore project, prioritized in their second round of expansion.
- →Some projects have been postponed slightly due to partner-related licensing delays but remain within acceptable timeframes.
- →The Southwest Bangalore 100-bed project is expected to start by end of Q2 FY27.
- →Capital investment will continue with a focus on affordable care philosophy, balancing leverage benefits, new growth verticals like integrated care, and customer returns.
- →The UK business acquisition involves no significant further capital deployment currently; focus is on improving earnings from existing capital.
- →Longer regulatory timelines for medical software certifications in the UK add approximately 4-6 months to plans but are a one-time effort.
- →The insurance business is investing in AI and claims management tools to improve sustainability but is currently small scale.
How does Narayana Hrudaya rank vs peers in Healthcare Services?
Pro feature1Narayana Hrudaya
Rev 3Mar 2
See full Healthcare Services sector rankings
How does Narayana Hrudaya rank in Healthcare Services?
Compare Narayana Hrudaya against every Healthcare Services company (Q1 FY27) on revenue, margins and earnings-call signals.